Clinical trial
Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With…
NCT00319449 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00319449 |
|---|---|
| Title | Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED) |
| Official title | A Single Center, Randomized, Parallel Groups, Placebo-Controlled Study Comparing The Efficacy, Safety, And Tolerability Of The Daily Co-administration Of Ezetimibe 10 Mg Or Ezetimibe Placebo To Ongoing Treatment With Atorvastatin 10 Mg In Subjects With Primary Hypercholesterolemia And Multiple… |
| Lead sponsor | Organon and Co, Industry |
| Collaborators | PT. Schering-Plough. Tbk Indonesia |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Coronary Arteriosclerosis |
| Intervention type | Drug |
| Interventions | Ezetimibe, Placebo, Atorvastatin 10 mg |
| Enrollment | 22 |
| Start date | Sep 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Feb 9, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: